Literature DB >> 31355782

Characterizing Mutational Load and Clonal Composition of Human Blood.

Axel Rosendahl Huber1, Freek Manders1, Rurika Oka1, Ruben van Boxtel2.   

Abstract

Hematopoietic stem and progenitor cells (HSPCs) gradually accumulate DNA mutations during a lifespan, which can contribute to age-associated diseases such as leukemia. Characterizing mutation accumulation can improve understanding of the etiology of age-associated diseases. Presented here is a method to catalogue somatic mutations in individual HSPCs, which is based on whole-genome sequencing (WGS) of clonal primary cell cultures. Mutations that are present in the original cell are shared by all cells in the clonal culture, whereas mutations acquired in vitro after cell sorting are present in a subset of cells. Therefore, this method allows for accurate detection of somatic mutations present in the genomes of individual HSPCs, which accumulate during life. These catalogues of somatic mutations can provide valuable insights into mutational processes active in the hematopoietic tissue and how these processes contribute to leukemogenesis. In addition, by assessing somatic mutations that are shared between multiple HSPCs of the same individual, clonal lineage relationships and population dynamics of blood populations can be determined. As this approach relies on in vitro expansion of single cells, the method is limited to hematopoietic cells with sufficient replicative potential.

Entities:  

Mesh:

Year:  2019        PMID: 31355782     DOI: 10.3791/59846

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  3 in total

1.  Whole-genome sequencing and mutational analysis of human cord-blood derived stem and progenitor cells.

Authors:  Axel Rosendahl Huber; Anaïs J C N van Leeuwen; Flavia Peci; Jurrian K de Kanter; Eline J M Bertrums; Ruben van Boxtel
Journal:  STAR Protoc       Date:  2022-05-06

2.  Antiviral treatment causes a unique mutational signature in cancers of transplantation recipients.

Authors:  Jurrian K de Kanter; Flavia Peci; Eline Bertrums; Axel Rosendahl Huber; Anaïs van Leeuwen; Markus J van Roosmalen; Freek Manders; Mark Verheul; Rurika Oka; Arianne M Brandsma; Marc Bierings; Mirjam Belderbos; Ruben van Boxtel
Journal:  Cell Stem Cell       Date:  2021-09-07       Impact factor: 24.633

3.  Human induced pluripotent stem cells display a similar mutation burden as embryonic pluripotent cells in vivo.

Authors:  Karlijn A L Hasaart; Freek Manders; Joske Ubels; Mark Verheul; Markus J van Roosmalen; Niels M Groenen; Rurika Oka; Ewart Kuijk; Susana M Chuva de Sousa Lopes; Ruben van Boxtel
Journal:  iScience       Date:  2022-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.